| Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376) |
|---|
| 01/21/2003 | US6509364 Interphenylene 7-oxabicyclic [2.2.1] heptane oxazoles as prostaglandin F2α antagonists |
| 01/21/2003 | US6509346 Chemokine receptor antagonists and methods of use therefor |
| 01/16/2003 | US20030013884 Compounds for use in 11-oxa prostaglandin synthesis |
| 01/16/2003 | US20030013786 Novel asymmetric halogen-alkyl alditol derivatives as nucleators and clarifiers for polyolefins, and polyolefin plastic compositions containing same |
| 01/16/2003 | US20030013677 Anticancer agents |
| 01/15/2003 | EP1275648A1 Epothilone minor constituents |
| 01/15/2003 | EP1274708A1 Herbicidal 3-heterocyclic substituted benzisothiazole and benzisoxazole compounds |
| 01/15/2003 | CN1390840A Artemisine arylether derivatives and their preparing process |
| 01/15/2003 | CN1390839A Composition of garcinolic acid compounds, its preparing process and medical composition using it as active component |
| 01/14/2003 | US6506911 Pyrano [3,2-d]-1,3-dioxin-8 ones |
| 01/14/2003 | US6506790 Compounds and methods |
| 01/09/2003 | WO2003002568A1 Carbohydrate derivatives |
| 01/09/2003 | WO2003002516A1 Process for prepraring of bridged tricyclic analogs of 2-(carboxycyclopropyl)glycine |
| 01/09/2003 | WO2003002515A1 Bridged tricyclic analogs of 2-(carboxycyclopropyl)glycine as inhibitors of glutamate transport |
| 01/09/2003 | WO2002076397A3 Telomerase inhibitors and methods of their use |
| 01/09/2003 | WO2002059111A3 Pyrazole compounds useful as protein kinase inhibitors |
| 01/09/2003 | US20030008953 Asymmetric dipolar multi-substituted alditol derivatives, methods of making thereof, and compositions and articles containing same |
| 01/09/2003 | US20030008951 Novel symmetrical halogenated and alkylated alditol derivatives and compositions and articles containing same |
| 01/09/2003 | US20030008891 Substituted 3',4' -Di-O-camphanoyl-(+)-cis-khellactone analogs, compositions thereof, and methods for using thereof |
| 01/09/2003 | US20030008232 (Meth)acrylate compounds having a norbornane, bicyclo(2.2.2) octane, 7-oxanorbornane or cyclohexane ring structure and a gamma-butyrolactone ring structure connected together by a linker, useful in forming polymer with high transparency |
| 01/09/2003 | CA2452092A1 Carbohydrate derivatives |
| 01/08/2003 | EP1273585A1 Chiral compounds |
| 01/08/2003 | EP1272491A1 Perylene-derivative based crystallization modifiers |
| 01/08/2003 | EP1272176A1 Adamantyl derivatives as anti-cancer agents |
| 01/08/2003 | EP1121364B1 Method for producing epothilone b and derivatives thereof |
| 01/08/2003 | EP0984934B1 Novel orally active iron (iii) chelators |
| 01/08/2003 | CN1390204A Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/08/2003 | CN1389465A Supercritical fluid extraction process of nim to produce mimbin extract |
| 01/08/2003 | CN1098266C Fused pyrrolo (2,3-c) carbazole-6-one which potentiate activity of gamma interferon |
| 01/07/2003 | US6504037 Reacting a cyclohexanedione or chromene-one derivative with 1,8-diazabicyclo(5.4.0)undec-7ene |
| 01/07/2003 | US6504036 2- and 2.5-substituted phenylketoenols |
| 01/07/2003 | US6503941 Ferulic ester derivative, 3,9-diferulylcoumestrol and cosmetic product containing same |
| 01/07/2003 | US6503937 Coloring agents for high molecular weight materials such as polymers |
| 01/07/2003 | US6503699 Method for photodecontamination of pathogens in blood using 5'-primary aminopsoralens |
| 01/03/2003 | WO2003000676A1 1,2,4-trioxolane antimalarials |
| 01/03/2003 | WO2003000673A2 Process for the preparation of simvastatin |
| 01/02/2003 | US20030004238 Novel asymmetric substituted benzaldehyde alditol derivatives and compositions and articles containing same |
| 01/02/2003 | US20030004164 Anticancer agents; autoimmune diseases |
| 01/02/2003 | US20030004161 Anticancer agents; autoimmune diseases |
| 01/02/2003 | US20030003379 Photoresist monomers, polymers thereof and photoresist compositons containing the same |
| 01/02/2003 | EP1268457A1 Reworkable composition of oxirane(s) or thiirane(s)-containing resin and curing agent |
| 01/02/2003 | EP1268437A1 Inhibitors of protein kinases |
| 01/02/2003 | EP1268368A2 Catalytic asymmetric desymmetrization of meso compounds |
| 01/02/2003 | EP1107972B1 Preparation process for manufacture and purification of mixtures of fluoran compounds and recording material comprising said mixtures of fluoran |
| 01/02/2003 | EP1073654A4 2,3-olefinic epothilone derivatives |
| 01/02/2003 | EP1073648A4 12,13-modified epothilone derivatives |
| 01/02/2003 | EP1073647A4 12,13-cyclopropane epothilone derivatives |
| 01/01/2003 | CN1388759A Medicine containing Anemonin as effective component for treating aseptic inflammation |
| 01/01/2003 | CN1388756A Ferulic ester derivative, 3,9-diferulylcoumestrol and cosmetic product containing same |
| 01/01/2003 | CN1388127A Pyromellitic acid dianhydride trapping method and apparatus |
| 12/31/2002 | US6500962 Production method of α-methylene-γ-butyrolactones |
| 12/27/2002 | WO2002102805A1 NEW USE Of CYCLOLIGNANS AND NEW CYCLOLIGNANS |
| 12/27/2002 | WO2002102804A1 New use of specific cyclolignans |
| 12/27/2002 | WO2002102803A1 Total synthesis of galanthamine, analogues and derivatives thereof |
| 12/27/2002 | WO2002102798A1 Uracil derivative and herbicide composition |
| 12/27/2002 | WO2002102793A2 Quinazolinediones as antibacterial agents |
| 12/27/2002 | WO2002102369A2 Agent for protection of retinal neurons |
| 12/27/2002 | CA2451475A1 Agent for protection of retinal neurons |
| 12/27/2002 | CA2446963A1 Quinazolinediones as antibacterial agents |
| 12/26/2002 | US20020198437 Method of manufacturing a soft hearing aid |
| 12/26/2002 | US20020198390 Acrylic esters containing fluorine at alpha-position and having a lactone ring introduced into the ester side chain thereof; useful as monomers to produce base polymers for use in chemically amplified resist compositions |
| 12/26/2002 | US20020198388 Sulfonamides which are aspartyl protease inhibitors; well suited for inhibiting HIV-1 and HIV-2 protease activity |
| 12/26/2002 | US20020198383 For use in regioselective and enantioselective alkylations of allylic substrates |
| 12/25/2002 | CN1387532A Naphthopyrans with heterocyclic in 5,6-position, preparation, and compositions and matrices contg. them |
| 12/25/2002 | CN1387524A Naphthopyrans having perfluoroalkyl substituent in position 5, preparation and compositions and matrices contg. them |
| 12/24/2002 | US6498257 2,3-olefinic epothilone derivatives |
| 12/19/2002 | WO2002074777A3 Pyranocoumarin compounds as a novel pharmacophore with anti-tb activity |
| 12/19/2002 | WO2002072858A3 Degradation of epothilones and ethynyl substituted epothilones |
| 12/19/2002 | WO2002050082A3 Inhibitors of papilloma virus |
| 12/19/2002 | US20020193473 Novel asymmetric monofluorinated benzaldehyde alditol derivatives and compositions and articles containing same |
| 12/19/2002 | US20020193423 Bioactive compound |
| 12/19/2002 | US20020193419 Amino acid derivatives of triptolide compounds as immune modulators and anticancer agents |
| 12/19/2002 | US20020193401 For therapy of depression, anxiety, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder attention deficit disorder,obsessive compulsive disorder, obesity, eating disorders, sexual dysfunction |
| 12/19/2002 | US20020193317 Using smilagenin, prazerigenin, an astragaloside, tigogenin, ruscogenin, hecogenin and diosgenin in manufacture of medicament for therayp of condition characterised by deficiency in postsynaptic membrane-bound receptor number |
| 12/19/2002 | DE4447770C2 Verfahren zur Herstellung von liposomal verkapseltem Taxol Process for the preparation of liposomally encapsulated Taxol |
| 12/18/2002 | CN1385433A Method for producing pyromellitic dianhydride |
| 12/18/2002 | CN1096466C New polysical form of artemisinin, its preparation process and its use in production of pharmaceuticals |
| 12/18/2002 | CN1096465C Isosorbierite-ester nitrate devirant and application used as survirability reduced vasodilator agent |
| 12/18/2002 | CN1096463C Procss for producing ecteinascidin and intermediate of said process |
| 12/17/2002 | US6495620 Asymmetric substituted benzaldehyde alditol derivatives and compositions and articles containing same |
| 12/12/2002 | WO2002098868A1 Epothilone derivatives |
| 12/12/2002 | WO2002098830A1 A method for isolating phenolic substances or juvabiones from wood comprising knotwood |
| 12/12/2002 | WO2002098363A2 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM |
| 12/12/2002 | US20020188140 Purification method for obtaining high-purity pmda |
| 12/12/2002 | US20020188136 Pesticides and herbicides |
| 12/12/2002 | CA2449843A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use, and processes for preparing them |
| 12/12/2002 | CA2449077A1 Epothilone derivatives |
| 12/11/2002 | EP1263735A1 Acid addition salts of imidazolidinones as reaction catalysts |
| 12/11/2002 | CN1095845C Method and device for production of lyophilized hydrochloride-1 beta, 10 beta-epoxy-13-dimethylamino-guaia-3(4)-en-6,12-olide |
| 12/11/2002 | CN1095844C Alcohol derivative of Triperygium wilfordii lactone, its prep. and application |
| 12/10/2002 | US6492533 Colorants comprising a chromophore having two methine moieties attached to a benzodifuranone backbone, wherein said moieties optionally have at least one poly(oxyalkylene) chain, preferably at least two such chains attached thereto are |
| 12/10/2002 | US6492440 Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials |
| 12/10/2002 | US6492416 4,5-diaryl-3(2H)-furanone derivatives as cyclooxygenase-2 inhibitors |
| 12/10/2002 | US6492390 Treating cyclooxygenase-2 mediated disorders. |
| 12/10/2002 | CA2198190C Functionalized bicyclic (meth) acrylates |
| 12/05/2002 | WO2002096413A1 Composition comprising demethylcantharidin in combination with platinum-containing anticancer agents and use thereof |
| 12/05/2002 | WO2002096348A2 Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment |
| 12/05/2002 | US20020183528 Alternatives for isocyanates in coating compositions and application processes |
| 12/05/2002 | US20020183512 Compounds for use in treatment of cancer |
| 12/05/2002 | US20020183423 Novel symmetric substituted benzaldehyde alditol derivatives and compositions and articles containing same |